HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection

被引:10
作者
Neukam, Karin [1 ]
Garcia-Rey, Silvia [1 ]
Cifuentes, Celia [1 ]
Macias, Juan [1 ]
Mira, Jose A. [1 ,2 ]
Vazquez, Maria J. [3 ]
Parra-Sanchez, Manuel [1 ]
Palomares, Jose C. [1 ]
Merchante, Nicolas [1 ]
Di Lello, Federico A. [1 ]
Pineda, Juan A. [1 ]
机构
[1] Hosp Univ Valme, Unit Infect Dis & Microbiol, Seville 41014, Spain
[2] Hosp Univ Valme, Dept Internal Med, Seville 41014, Spain
[3] Ctr Penitenciario Sevilla, Med Serv, Alcala De Guadaira 41500, Spain
关键词
Hepatitis C virus; HIV; RNA load; Pegylated interferon; Ribavirin; Polymerase chain reaction; HEPATITIS-C VIRUS; INTERFERON PLUS RIBAVIRIN; ANTIRETROVIRAL THERAPY; PREDICTION; COHORT;
D O I
10.1016/j.antiviral.2012.06.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of HIV coinfection on plasma hepatitis C virus (HCV) RNA load has not been reliably evaluated. We analyzed plasma HCV RNA load in 396 HCV-monoinfected and 467 HIV/HCV-coinfected patients. Median HCV RNA concentrations (interquartile range) in HCV-monoinfected patients were 5.88 (5.3-6.2) log(10) IU/mL versus 5.96 (5.6-6.5) log(10) IU/mL in HIV/HCV-coinfected individuals (p = 0.033) as determined with the Cobas Amplicor Test and 6.06 (5.4-5.7) log(10) IU/mL versus 6.3 (5.5-6.9) log(10) IU/mL (p = 0.026) using the Cobas TaqMan System. The plasma HCV RNA load in patients with HIV infection and undetectable plasmatic HIV RNA was similar to that observed in HCV-monoinfected individuals [6.02 (5.45-6.61) log(10) IU/mL versus 6.01 (5.36-6.59) log(10) IU/mL, respectively (p = 1.0)]. In conclusion, HIV coinfection tends to be associated with higher plasma HCV RNA load, however, the magnitude of the differences is small and this effect can be counterbalanced with antiviral therapy. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:212 / 215
页数:4
相关论文
共 47 条
  • [31] Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis C
    Morello, Judit
    Soriano, Vincent
    Barreiro, Pablo
    Medrano, Jose
    Madejon, Antonio
    Gonzalez-Pardo, Gema
    Jimenez-Nacher, Inmaculada
    Gonzalez-Lahoz, Juan
    Rodriguez-Novoa, Sonia
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (04) : 1647 - 1649
  • [32] Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting
    Reiberger, Thomas
    Obermeier, Martin
    Payer, Berit A.
    Baumgarten, Axel
    Weitner, Lutwin
    Moll, Arend
    Christensen, Stefan
    Koeppe, Siegfried
    Kundi, Michael
    Rieger, Armin
    Peck-Radosavljevic, Markus
    ANTIVIRAL THERAPY, 2011, 16 (06) : 815 - 824
  • [33] Hepatic Decompensation in Patients With HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) Triple Infection Versus HIV/HCV Coinfection and the Effect of Anti-HBV Nucleos(t)ide Therapy
    Lo Re, Vincent, III
    Wang, Li
    Devine, Scott
    Baser, Onur
    Olufade, Temitope
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (07) : 1027 - 1031
  • [34] Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel
    Soriano, V
    Sulkowski, M
    Bergin, C
    Hatzakis, A
    Cacoub, P
    Katlama, C
    Cargnel, A
    Mauss, S
    Dieterich, D
    Moreno, S
    Ferrari, C
    Poynard, T
    AIDS, 2002, 16 (06) : 813 - 828
  • [35] Hepatitis C virus (HCV) tends to associate preferentially with high-density lipoproteins by standard ultracentrifugal fractionation of plasma from patients with chronic HCV infection
    Manzini, P
    Dusheiko, GM
    Brown, DJC
    Khakoo, SI
    Owen, JS
    HEPATOLOGY RESEARCH, 1998, 11 (03) : 158 - 165
  • [36] Undetectable hepatitis C virus RNA during syphilis infection in two HIV/HCV-co-infected patients
    Salado-Rasmussen, Kirsten
    Knudsen, Andreas
    Krarup, Henrik Bygum
    Katzenstein, Terese Lea
    Gerstoft, Jan
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2014, 46 (09) : 617 - 623
  • [37] Serial changes in renal indices in chronic HCV patients with and without HIV co-infection receiving sofosbuvir and tenofovir-based therapies
    Abdel Alem, Shereen
    El Garhy, Naeema
    El Khateeb, Engy
    Khalil, Mahmoud
    Cordie, Ahmed
    Elsharkawy, Aisha
    Fouad, Rabab
    Esmat, Gamal
    Abdelbary, Mohammad Salah
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2023, 117 (04) : 285 - 296
  • [38] HCV-RNA qualitative assay based on transcription mediated amplification improves the detection of hepatitis C virus infection in patients on hemodialysis: Results from five hemodialysis units in central Greece
    Rigopoulou, EI
    Stefanidis, I
    Liaskos, C
    Zervou, EK
    Rizos, C
    Mina, P
    Zachou, K
    Syrganis, C
    Patsidis, E
    Kyriakopoulos, G
    Sdrakas, L
    Tsianas, N
    Dalekos, GN
    JOURNAL OF CLINICAL VIROLOGY, 2005, 34 (01) : 81 - 85
  • [39] Expression of selected genes in liver biopsy specimens in relation to early virological response in patients with chronic hepatitis C with HCV mono- and HIV/HCV co-infection
    Jablonowska, Elzbieta
    Wojcik, Kamila
    Koslinska-Berkan, Ewa
    Szymanska, Bozena
    Omulecka, Aleksandra
    Piekarska, Anna
    ARCHIVES OF VIROLOGY, 2014, 159 (06) : 1365 - 1371
  • [40] CD4+ and CD8+ Regulatory T Cells (Tregs) are Elevated and Display an Active Phenotype in Patients with Chronic HCV Mono-Infection and HIV/HCV Co-Infection
    Hartling, H. J.
    Gaardbo, J. C.
    Ronit, A.
    Knudsen, L. S.
    Ullum, H.
    Vainer, B.
    Clausen, M. R.
    Skogstrand, K.
    Gerstoft, J.
    Nielsen, S. D.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2012, 76 (03) : 294 - 305